Is NRXS or POCI more undervalued in 2026?

CirclFi compares Neuraxis, Inc. (NRXS) and Precision Optics Corporation, I (POCI) using 13 institutional-grade valuation models. NRXS has a Quality of Company score of 6.9/10 while POCI scores 5.9/10.

Which is a better buy — NRXS or POCI?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do NRXS and POCI valuations compare?

NRXS at $7.41 and POCI at $5.44 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

NRXS vs POCI Valuation Comparison 2026 — Intrinsic Value Analysis

NRXS

Electromedical & Electrotherapeutic Apparatus

Neuraxis, Inc.

Quality

6.9

out of 10

Value Trap

SAFE

Price

$7.41

Last close

Models

10/13

Active

POCI

Electromedical & Electrotherapeutic Apparatus

Precision Optics Corporation, I

Quality

5.9

out of 10

Value Trap

LOW

Price

$5.44

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	NRXS Fair Value	NRXS Upside	POCI Fair Value	POCI Upside
Bayesian DCF	Intrinsic	$2.02	-72.7%	$1.82	-66.5%
Earnings Power Value	Intrinsic	$1.57	-80.6%	$0.53	-87.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for NRXS vs POCI — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

NRXS vs POCI — Which Stock Is More Undervalued?

NRXS scores higher with a 6.9/10 quality rating vs POCI's 5.9/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Neuraxis, Inc. (NRXS) and Precision Optics Corporation, I (POCI) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

NRXS currently trades at $7.41 with a QOC of 6.9/10, while POCI trades at $5.44 with a QOC of 5.9/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).